首頁 › 間質性肺病 › 明尼蘇達 › Minneapolis
Minneapolis, MN 的 間質性肺病 臨床試驗
8 項針對 間質性肺病 的研究正在 Minneapolis(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
招募中3 期
- University of Minnesota, Minneapolis
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
招募中3 期
- University of Minnesota, Minneapolis
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中2 期
- University of Minnesota, Minneapolis
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
招募中
- University of Minnesota, Minneapolis
Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
招募中觀察性研究
- University of Minnesota, Minneapolis
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
招募中3 期
- University of Minnesota Health Clinical Research Unit (CRU), Minneapolis
TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
招募中觀察性研究
- University of Minnesota, Minneapolis
Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
招募中
- University of Minnesota, Minneapolis
其他城市的 間質性肺病 試驗
- New York City, NY18 項研究
- Philadelphia, PA16 項研究
- Los Angeles, CA14 項研究
- Kansas City, KS13 項研究
- Durham, NC13 項研究
- Charleston, SC13 項研究
- Chicago, IL12 項研究
- Houston, TX12 項研究
- Aurora, CO11 項研究
- Ann Arbor, MI11 項研究
- Phoenix, AZ9 項研究
- Salt Lake City, UT9 項研究
Minneapolis 的其他研究
- 乳癌27 項研究
- 非小細胞肺癌26 項研究
- 卵巢癌24 項研究
- 前列腺癌23 項研究
- 癌症(所有類型)22 項研究
- 心臟衰竭21 項研究
- 肺癌20 項研究
- 急性髓系白血病20 項研究
- 大腸直腸癌19 項研究
- 子宮內膜癌18 項研究
- 帕金森氏症17 項研究
- 心血管疾病15 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月5日。各研究自行設定資格標準;由研究團隊決定參與者資格。